Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease

M. Watanabe, S. Tsuru, Y. Zinnaka, T. Yoshida, Sadakazu Aiso, T. Hibi, H. Asakura, M. Tsuchiya

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effect of sera from 17 patients with Crohn's disease, 8 with ulcerative colitis or 5 with intestinal tuberculosis on the proliferative response of mouse spleen cells induced by phytohemagglutinin (PHA) was studied. Sera from patients with Crohn's disease markedly suppressed the blastogenesis of mouse spleen cells (S.I. = 6.8 ± 2.0, % suppression = 83%), as compared with normal sera (S.I. = 41.0 ± 5.2, p < 0.001, % suppression = 0). Conversely, ulcerative colitis sera did not suppress the blastogenesis of mouse spleen cells (S.I. = 43.5 ± 8.7, % suppression = -6%), nor the sera of intestinal tuberculosis (S.I. = 38.9 ± 4.0, % suppression = 6%). Thus, we confirmed the possible existence of immunosuppressive factors in Crohn's disease. Moreover, immunosuppressive factors in Crohn's disease were characterized for biochemical properties. The approximate molecular weight is 45,000 estimated by diafiltration and gel filtration on a Sephadex G-75 column. Analytical isoelectric focusing showed an increased amount of acidic protein in fractionated sera (m.w. ranging 30,000-50,000) from patients with Crohn's disease and ulcerative colitis, in comparison with that in normal sera. Furthermore, the main peak of this acidic protein in Crohn's disease was an isoelectric point (pI) of 2.8, while the pI of that from ulcerative colitis was 3.0. These results suggest that qualitative differences of such acidic protein may serve to discriminate between the sera of Crohn's disease and ulcerative colitis.

Original languageEnglish
Pages (from-to)13-19
Number of pages7
JournalJournal of Clinical and Laboratory Immunology
Volume17
Issue number1
Publication statusPublished - 1985 Oct 10
Externally publishedYes

ASJC Scopus subject areas

  • Immunology

Cite this

Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease. / Watanabe, M.; Tsuru, S.; Zinnaka, Y.; Yoshida, T.; Aiso, Sadakazu; Hibi, T.; Asakura, H.; Tsuchiya, M.

In: Journal of Clinical and Laboratory Immunology, Vol. 17, No. 1, 10.10.1985, p. 13-19.

Research output: Contribution to journalArticle

Watanabe, M, Tsuru, S, Zinnaka, Y, Yoshida, T, Aiso, S, Hibi, T, Asakura, H & Tsuchiya, M 1985, 'Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease', Journal of Clinical and Laboratory Immunology, vol. 17, no. 1, pp. 13-19.
Watanabe, M. ; Tsuru, S. ; Zinnaka, Y. ; Yoshida, T. ; Aiso, Sadakazu ; Hibi, T. ; Asakura, H. ; Tsuchiya, M. / Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease. In: Journal of Clinical and Laboratory Immunology. 1985 ; Vol. 17, No. 1. pp. 13-19.
@article{89e006f231814e66baad11aaf9eceacd,
title = "Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease",
abstract = "The effect of sera from 17 patients with Crohn's disease, 8 with ulcerative colitis or 5 with intestinal tuberculosis on the proliferative response of mouse spleen cells induced by phytohemagglutinin (PHA) was studied. Sera from patients with Crohn's disease markedly suppressed the blastogenesis of mouse spleen cells (S.I. = 6.8 ± 2.0, {\%} suppression = 83{\%}), as compared with normal sera (S.I. = 41.0 ± 5.2, p < 0.001, {\%} suppression = 0). Conversely, ulcerative colitis sera did not suppress the blastogenesis of mouse spleen cells (S.I. = 43.5 ± 8.7, {\%} suppression = -6{\%}), nor the sera of intestinal tuberculosis (S.I. = 38.9 ± 4.0, {\%} suppression = 6{\%}). Thus, we confirmed the possible existence of immunosuppressive factors in Crohn's disease. Moreover, immunosuppressive factors in Crohn's disease were characterized for biochemical properties. The approximate molecular weight is 45,000 estimated by diafiltration and gel filtration on a Sephadex G-75 column. Analytical isoelectric focusing showed an increased amount of acidic protein in fractionated sera (m.w. ranging 30,000-50,000) from patients with Crohn's disease and ulcerative colitis, in comparison with that in normal sera. Furthermore, the main peak of this acidic protein in Crohn's disease was an isoelectric point (pI) of 2.8, while the pI of that from ulcerative colitis was 3.0. These results suggest that qualitative differences of such acidic protein may serve to discriminate between the sera of Crohn's disease and ulcerative colitis.",
author = "M. Watanabe and S. Tsuru and Y. Zinnaka and T. Yoshida and Sadakazu Aiso and T. Hibi and H. Asakura and M. Tsuchiya",
year = "1985",
month = "10",
day = "10",
language = "English",
volume = "17",
pages = "13--19",
journal = "Journal of Clinical and Laboratory Immunology",
issn = "0141-2760",
publisher = "Teviot Scientific Publications Ltd.",
number = "1",

}

TY - JOUR

T1 - Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease

AU - Watanabe, M.

AU - Tsuru, S.

AU - Zinnaka, Y.

AU - Yoshida, T.

AU - Aiso, Sadakazu

AU - Hibi, T.

AU - Asakura, H.

AU - Tsuchiya, M.

PY - 1985/10/10

Y1 - 1985/10/10

N2 - The effect of sera from 17 patients with Crohn's disease, 8 with ulcerative colitis or 5 with intestinal tuberculosis on the proliferative response of mouse spleen cells induced by phytohemagglutinin (PHA) was studied. Sera from patients with Crohn's disease markedly suppressed the blastogenesis of mouse spleen cells (S.I. = 6.8 ± 2.0, % suppression = 83%), as compared with normal sera (S.I. = 41.0 ± 5.2, p < 0.001, % suppression = 0). Conversely, ulcerative colitis sera did not suppress the blastogenesis of mouse spleen cells (S.I. = 43.5 ± 8.7, % suppression = -6%), nor the sera of intestinal tuberculosis (S.I. = 38.9 ± 4.0, % suppression = 6%). Thus, we confirmed the possible existence of immunosuppressive factors in Crohn's disease. Moreover, immunosuppressive factors in Crohn's disease were characterized for biochemical properties. The approximate molecular weight is 45,000 estimated by diafiltration and gel filtration on a Sephadex G-75 column. Analytical isoelectric focusing showed an increased amount of acidic protein in fractionated sera (m.w. ranging 30,000-50,000) from patients with Crohn's disease and ulcerative colitis, in comparison with that in normal sera. Furthermore, the main peak of this acidic protein in Crohn's disease was an isoelectric point (pI) of 2.8, while the pI of that from ulcerative colitis was 3.0. These results suggest that qualitative differences of such acidic protein may serve to discriminate between the sera of Crohn's disease and ulcerative colitis.

AB - The effect of sera from 17 patients with Crohn's disease, 8 with ulcerative colitis or 5 with intestinal tuberculosis on the proliferative response of mouse spleen cells induced by phytohemagglutinin (PHA) was studied. Sera from patients with Crohn's disease markedly suppressed the blastogenesis of mouse spleen cells (S.I. = 6.8 ± 2.0, % suppression = 83%), as compared with normal sera (S.I. = 41.0 ± 5.2, p < 0.001, % suppression = 0). Conversely, ulcerative colitis sera did not suppress the blastogenesis of mouse spleen cells (S.I. = 43.5 ± 8.7, % suppression = -6%), nor the sera of intestinal tuberculosis (S.I. = 38.9 ± 4.0, % suppression = 6%). Thus, we confirmed the possible existence of immunosuppressive factors in Crohn's disease. Moreover, immunosuppressive factors in Crohn's disease were characterized for biochemical properties. The approximate molecular weight is 45,000 estimated by diafiltration and gel filtration on a Sephadex G-75 column. Analytical isoelectric focusing showed an increased amount of acidic protein in fractionated sera (m.w. ranging 30,000-50,000) from patients with Crohn's disease and ulcerative colitis, in comparison with that in normal sera. Furthermore, the main peak of this acidic protein in Crohn's disease was an isoelectric point (pI) of 2.8, while the pI of that from ulcerative colitis was 3.0. These results suggest that qualitative differences of such acidic protein may serve to discriminate between the sera of Crohn's disease and ulcerative colitis.

UR - http://www.scopus.com/inward/record.url?scp=0021858103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021858103&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 13

EP - 19

JO - Journal of Clinical and Laboratory Immunology

JF - Journal of Clinical and Laboratory Immunology

SN - 0141-2760

IS - 1

ER -